Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FVR
3051
FrontView REIT
FVR
$484M
| $1.43M | ﹤0.01% |
119,429
+104,928
| +724% | +$1.24M |
|
3052
Arhaus
ARHS
$1.39B
| $1.43M | ﹤0.01% |
164,854
+84,798
| +106% | +$708K |
|
3053
First Community Bankshares
FCBC
$934M
| $1.43M | ﹤0.01% |
36,487
+11,274
| +45% | +$431K |
|
3054
CALL
Modine Manufacturing
MOD
$11.1B
| $1.43M | ﹤0.01% |
+14,500
| New | +$1.29M |
|
3055
Donegal Group Class A
DGICA
$699M
| $1.42M | ﹤0.01% |
71,053
+5,313
| +8% | +$103K |
|
3056
Ooma
OOMA
$561M
| $1.42M | ﹤0.01% |
110,152
+23,747
| +27% | +$302K |
|
|
FARO
3057
DELISTED
Faro Technologies
FARO
| $1.42M | ﹤0.01% |
32,294
-15,559
| -33% | -$569K |
|
|
PLYM
3058
DELISTED
Plymouth Industrial REIT
PLYM
| $1.42M | ﹤0.01% |
88,143
+17,722
| +25% | +$277K |
|
3059
Central Garden & Pet Co
CENT
$2.79B
| $1.42M | ﹤0.01% |
40,236
+8,363
| +26% | +$296K |
|
3060
CALL
Telesat
TSAT
$787M
| $1.42M | ﹤0.01% |
57,900
| – | – |
|
|
ORC
3061
Orchid Island Capital
ORC
$1.33B
| $1.41M | ﹤0.01% |
201,610
+118,098
| +141% | +$818K |
|
3062
PUT
Fastly Inc
FSLY
$4.73B
| $1.41M | ﹤0.01% |
200,000
| – | – |
|
3063
Cars.com
CARS
$658M
| $1.41M | ﹤0.01% |
119,010
+33,561
| +39% | +$370K |
|
|
KE
3064
Kimball Electronics
KE
$646M
| $1.41M | ﹤0.01% |
73,174
+16,068
| +28% | +$269K |
|
|
AMED
3065
DELISTED
Amedisys
AMED
| $1.4M | ﹤0.01% |
14,221
-25,085
| -64% | -$2.37M |
|
3066
PUT
AstraZeneca
AZN
$241B
| $1.4M | ﹤0.01% |
10,000
-8,500
| -46% | -$1.19M |
|
3067
PUT
uniQure
QURE
$3.24B
| $1.39M | ﹤0.01% |
+100,000
| New | +$1.35M |
|
3068
PUT
Merck
MRK
$332B
| $1.39M | ﹤0.01% |
17,600
-103,200
| -85% | -$8.2M |
|
3069
Global E Online
GLBE
$7.04B
| $1.39M | ﹤0.01% |
41,506
-30,980
| -43% | -$1.05M |
|
|
SEMR
3070
DELISTED
Semrush
SEMR
| $1.39M | ﹤0.01% |
153,437
+66,035
| +76% | +$639K |
|
3071
CALL
MSCI
MSCI
$41.3B
| $1.38M | ﹤0.01% |
+2,400
| New | +$1.33M |
|
|
CTLP
3072
DELISTED
Cantaloupe
CTLP
| $1.38M | ﹤0.01% |
125,887
+33,064
| +36% | +$286K |
|
3073
Carriage Services
CSV
$566M
| $1.38M | ﹤0.01% |
30,207
+15,637
| +107% | +$653K |
|
3074
Energy Recovery
ERII
$407M
| $1.38M | ﹤0.01% |
107,610
+29,006
| +37% | +$393K |
|
3075
Corvus Pharmaceuticals
CRVS
$1.27B
| $1.37M | ﹤0.01% |
343,526
+260,295
| +313% | +$947K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.